PPP
AVEO

Private Portfolio Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Private Portfolio Partners’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,100
Closed -$82K – 200
2018
Q4 		$82K Buy
+5,100
New +$112K 0.05% 177

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Private Portfolio Partners's AVEO Position: Q1 2019 in Review

Private Portfolio Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 5,100 shares — an estimated $82K sold.

Private Portfolio Partners first reported a position in AVEO in Q4 2018 and held it in 1 quarter. The position peaked at $82K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Private Portfolio Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Private Portfolio Partners sold 5,100 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $82K.
  • Private Portfolio Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Private Portfolio Partners's AVEO Pharmaceuticals, Inc. position peaked at $82K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Private Portfolio Partners's 13F filing for Q1 2019, filed 10 May 2019.